世界の人工心肺機械市場予測（～2028年）：シングルローラーポンプHLM、ダブルローラーポンプHLM

• 英文タイトル：Global Artificial Cardiopulmonary Machine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E7609 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

人工心肺機械市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の人工心肺機械の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 人工心肺機械市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・シングルローラーポンプHLM、ダブルローラーポンプHLM 用途別セグメントは次のように区分されます。 ・心臓外科、肺移植手術、急性呼吸不全治療、その他 世界の人工心肺機械市場の主要な市場プレーヤーは以下のとおりです。 ・LivaNova (Sorin)、Getinge (Maquet)、Medtronic、Terumo CV Group、Braile Biomedica、Tianjin Medical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、人工心肺機械製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な人工心肺機械メーカーの企業概要、2019年～2022年までの人工心肺機械の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な人工心肺機械メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別人工心肺機械の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの人工心肺機械の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での人工心肺機械市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および人工心肺機械の産業チェーンを掲載しています。 ・第13、14、15章では、人工心肺機械の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：LivaNova (Sorin)、Getinge (Maquet)、Medtronic、Terumo CV Group、Braile Biomedica、Tianjin Medical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：シングルローラーポンプHLM、ダブルローラーポンプHLM ・用途別分析2017年-2028年：心臓外科、肺移植手術、急性呼吸不全治療、その他 ・人工心肺機械の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・人工心肺機械のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・人工心肺機械のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・人工心肺機械の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・人工心肺機械の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Artificial Cardiopulmonary Machine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Artificial Cardiopulmonary Machine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cardiac Surgery accounting for % of the Artificial Cardiopulmonary Machine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Roller Pump HLM segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Artificial Cardiopulmonary Machine include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, and Braile Biomedica, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Artificial Cardiopulmonary Machine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Roller Pump HLM
Double Roller Pump HLM
Market segment by Application can be divided into
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
The key market players for global Artificial Cardiopulmonary Machine market are listed below:
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Cardiopulmonary Machine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Cardiopulmonary Machine, with price, sales, revenue and global market share of Artificial Cardiopulmonary Machine from 2019 to 2022.
Chapter 3, the Artificial Cardiopulmonary Machine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Cardiopulmonary Machine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Cardiopulmonary Machine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Cardiopulmonary Machine.
Chapter 13, 14, and 15, to describe Artificial Cardiopulmonary Machine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Artificial Cardiopulmonary Machine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Artificial Cardiopulmonary Machine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Single Roller Pump HLM
1.2.3 Double Roller Pump HLM
1.3 Market Analysis by Application
1.3.1 Overview: Global Artificial Cardiopulmonary Machine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Global Artificial Cardiopulmonary Machine Market Size & Forecast
1.4.1 Global Artificial Cardiopulmonary Machine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Artificial Cardiopulmonary Machine Sales in Volume (2017-2028)
1.4.3 Global Artificial Cardiopulmonary Machine Price (2017-2028)
1.5 Global Artificial Cardiopulmonary Machine Production Capacity Analysis
1.5.1 Global Artificial Cardiopulmonary Machine Total Production Capacity (2017-2028)
1.5.2 Global Artificial Cardiopulmonary Machine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Artificial Cardiopulmonary Machine Market Drivers
1.6.2 Artificial Cardiopulmonary Machine Market Restraints
1.6.3 Artificial Cardiopulmonary Machine Trends Analysis
2 Manufacturers Profiles
2.1 LivaNova (Sorin)
2.1.1 LivaNova (Sorin) Details
2.1.2 LivaNova (Sorin) Major Business
2.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Product and Services
2.1.4 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Getinge (Maquet)
2.2.1 Getinge (Maquet) Details
2.2.2 Getinge (Maquet) Major Business
2.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Product and Services
2.2.4 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Artificial Cardiopulmonary Machine Product and Services
2.3.4 Medtronic Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Terumo CV Group
2.4.1 Terumo CV Group Details
2.4.2 Terumo CV Group Major Business
2.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Product and Services
2.4.4 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Braile Biomedica
2.5.1 Braile Biomedica Details
2.5.2 Braile Biomedica Major Business
2.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Product and Services
2.5.4 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Tianjin Medical
2.6.1 Tianjin Medical Details
2.6.2 Tianjin Medical Major Business
2.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Product and Services
2.6.4 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Artificial Cardiopulmonary Machine Breakdown Data by Manufacturer
3.1 Global Artificial Cardiopulmonary Machine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Artificial Cardiopulmonary Machine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Artificial Cardiopulmonary Machine
3.4 Market Concentration Rate
3.4.1 Top 3 Artificial Cardiopulmonary Machine Manufacturer Market Share in 2021
3.4.2 Top 6 Artificial Cardiopulmonary Machine Manufacturer Market Share in 2021
3.5 Global Artificial Cardiopulmonary Machine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Artificial Cardiopulmonary Machine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Artificial Cardiopulmonary Machine Market Size by Region
4.1.1 Global Artificial Cardiopulmonary Machine Sales in Volume by Region (2017-2028)
4.1.2 Global Artificial Cardiopulmonary Machine Revenue by Region (2017-2028)
4.2 North America Artificial Cardiopulmonary Machine Revenue (2017-2028)
4.3 Europe Artificial Cardiopulmonary Machine Revenue (2017-2028)
4.4 Asia-Pacific Artificial Cardiopulmonary Machine Revenue (2017-2028)
4.5 South America Artificial Cardiopulmonary Machine Revenue (2017-2028)
4.6 Middle East and Africa Artificial Cardiopulmonary Machine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Artificial Cardiopulmonary Machine Sales in Volume by Type (2017-2028)
5.2 Global Artificial Cardiopulmonary Machine Revenue by Type (2017-2028)
5.3 Global Artificial Cardiopulmonary Machine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Artificial Cardiopulmonary Machine Sales in Volume by Application (2017-2028)
6.2 Global Artificial Cardiopulmonary Machine Revenue by Application (2017-2028)
6.3 Global Artificial Cardiopulmonary Machine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
7.2 North America Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
7.3 North America Artificial Cardiopulmonary Machine Market Size by Country
7.3.1 North America Artificial Cardiopulmonary Machine Sales in Volume by Country (2017-2028)
7.3.2 North America Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
8.2 Europe Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
8.3 Europe Artificial Cardiopulmonary Machine Market Size by Country
8.3.1 Europe Artificial Cardiopulmonary Machine Sales in Volume by Country (2017-2028)
8.3.2 Europe Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
9.2 Asia-Pacific Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
9.3 Asia-Pacific Artificial Cardiopulmonary Machine Market Size by Region
9.3.1 Asia-Pacific Artificial Cardiopulmonary Machine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Artificial Cardiopulmonary Machine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
10.2 South America Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
10.3 South America Artificial Cardiopulmonary Machine Market Size by Country
10.3.1 South America Artificial Cardiopulmonary Machine Sales in Volume by Country (2017-2028)
10.3.2 South America Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
11.2 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
11.3 Middle East & Africa Artificial Cardiopulmonary Machine Market Size by Country
11.3.1 Middle East & Africa Artificial Cardiopulmonary Machine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Artificial Cardiopulmonary Machine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Artificial Cardiopulmonary Machine
12.3 Artificial Cardiopulmonary Machine Production Process
12.4 Artificial Cardiopulmonary Machine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Artificial Cardiopulmonary Machine Typical Distributors
13.3 Artificial Cardiopulmonary Machine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---